Search by tag «Cancer» 25 results
Chemists at ITMO University have designed an AI-based platform that identifies nanoparticles with selective cytotoxicity to cancer cells. According to the corresponding article in Small, the system should be expected to optimize particle synthesis and reduce the side effects of cancer treatment.
Fittingly for this “anniversary” installment of our science digest, we have a whole slew of research updates to share: from anti-cancer and computing breakthroughs to a dive into the science of memes.
In collaboration, researchers from two Russian universities have developed compounds that trigger programmable death in cancer cells and tested their efficiency on cervical tumor samples. The new compounds do not affect healthy cells, their toxicity being eight times lower than that of doxorubicin, a commonly used cancer treatment. This means that in the future, treatments using the new compound may help avoid the common side effects of chemotherapy.
Twice a month, we invite you to take in the latest breakthroughs and successes of ITMO University’s students and scientists. Today, we’ve got plenty of research updates to share – as well as a couple of impressive success stories from our industrious graduates!
Started by a single mutation in a cell, cancer is one of the leading causes of death worldwide that killed nearly 10 million people in 2020. In the article, Evgeniya Platonova, a Master’s student at ITMO’s SCAMT Institute, explains what cancer is and how it starts, and shares what medical advances are already helping to combat the disease.
It’s been a while since our latest digest of all things science at ITMO – so strap in for an extra-packed edition! From staggering medical breakthroughs to a whole slew of new Master’s programs, there’s plenty to get you excited about the future of research.
In their study of correlations between intestinal microbiota and melanoma treatment results, researchers from ITMO University and the Lopukhin Federal Research and Clinical Center of Physical-Chemical Medicine have come across functional biomarkers that can predict immunotherapy efficacy and beneficial bacteria that enhance immune responses in patients through stimulating the development of T-cells. The findings can be potentially used to develop a pre-treatment diagnostic test and issue recommendations for gut microbiome correction. The results of the study were published in mSystems.
Cancer is the second most common death cause in the world, which in 2020 took the lives of nearly 10 million people – every sixth death, according to WHO. Globally, researchers are developing new, more efficient treatments for oncological diseases. Scientists from ITMO also contribute to these efforts: recently, they have come up with a universally applicable magnetic particle from zinc ferrite and manganese ferrite that can facilitate both cancer diagnostics and treatment. The new method increases the efficiency of radiotherapy by 40%, and during magnetic hyperthermia it can heat cancer cells in several seconds, while also securing less exposure for the healthy cells. This study was published in Journal of Materials Chemistry B.
Today, we’ve got a whole lot of research to share with you, dear reader: from an anti-art forgery invention to a promising cancer treatment. And after that, we’ve got insights into the art of lighting design, a celebration of holography, and even a pop-sci collaboration with the city’s top bakery chain.
In recent years, oncological diseases have become one of the most wide-spread causes of death in developed countries – and despite the abundant new diagnostics and treatment methods, fighting cancer is still a challenge. Nearly all known treatments have significant side effects, while some of them are even helpless against more persistent cancer cells. One solution to this problem is photothermal therapy, on its own or in combination with other treatments. Researchers from ITMO University have suggested a new method to treat melanoma more effectively and safely using gold nanoparticles. Read on to learn more about the new method.